• Doxorubicin as a Probe of Persister Ferroptosis

  2026-09-11

  Doxorubicin is more than a conventional cancer chemotherapy drug: it can serve as a controlled selective pressure for studying drug-tolerant persister states. This article connects Adriamycin-mediated DNA damage with lipidomic and mitochondrial features that may expose persister cells to ferroptosis.

• 1-myristoylglycerophosphocholine Research Guide

  2026-09-10

  1-myristoylglycerophosphocholine, also called 14:0 Lyso-PC, is a phosphocholine lysophospholipid for studying lipid-mediated cellular responses. Product data support its use in smooth muscle and signaling assays, while peer-reviewed evidence shows that LysoPC accumulation can promote fibroblast activation in experimental pulmonary fibrosis.

• Fenipentol (1-Phenyl-1-pentanol) Research Guide

  2026-09-10

  Fenipentol, also called 1-Phenyl-1-pentanol, is a small molecule associated with Ligusticum chuanxiong cortex chemistry and estrogen receptor α docking. Its historical secretion data support use as a research probe for choleretic, pancreatic, and gastrointestinal physiology studies, not as evidence of current clinical efficacy.

• Baicalin Methyl Ester: Intestinal Barrier Workflow

  2026-09-09

  Baicalin methyl ester provides a practical, pathway-oriented tool for studying LPS-induced intestinal barrier damage in MODE-K cells and mouse models. Its value lies in pairing cytokine suppression with MLCK/ZO-1 and tight-junction readouts, enabling stronger mechanism-to-phenotype validation than a single inflammatory marker.

• (Z)-4-Hydroxytamoxifen: Assay Design by Mechanism

  2026-09-09

  Explore (Z)-4-Hydroxytamoxifen as a high-affinity ER probe through a mechanism-first assay framework. This article connects estrogen receptor modulation with lessons from targeted nanoparticle research while clearly separating validated biology from experimental extrapolation.

• Obacunone, Akt/p53, and Ferroptosis in Ovarian Cancer

  2026-09-08

  A 2025 study identifies obacunone as a potential inducer of ferroptosis in ovarian cancer by linking reduced Akt phosphorylation with increased p53 signaling, impaired antioxidant defense, and lipid peroxidation. Its use of Fer-1 and the Akt activator SC 79 provides a pharmacological framework for testing pathway involvement, while the cell and xenograft results support further investigation rather than clinical conclusions.

• Gemini QACs: Broad-Spectrum Biocidal Design

  2026-09-08

  The reference study synthesizes 16 octenidine-inspired gemini quaternary ammonium compounds and identifies derivatives with improved combinations of antibacterial, antifungal, virucidal, solubility, and cytotoxicity profiles. Its structure–activity analysis shows how cationic architecture and polarity can be tuned to address limitations of established disinfectants while retaining broad membrane-active biocidal behavior.

• Western Secondary Antibody Dilution Buffer: Assay Control

  2026-09-07

  Discover how Western Secondary Antibody Dilution Buffer can improve assay consistency when studying NHE1, calcium-dependent ROS, and NLRP3 signaling. This guide connects reagent handling with mechanistic interpretation, control design, and practical Western blot decisions.

• Honokiol Workflows for NF-κB and T-Cell Assays

  2026-09-07

  Use Honokiol to connect NF-κB, oxidative-stress, tumor-angiogenesis, and CD8+ T-cell metabolic assays within one controlled experimental design. The workflow emphasizes solvent control, orthogonal viability measurements, and a hypothesis-driven translation of recent PKM splicing findings.

• ER–Ca2+–Calpain Switch in Starved Bombyx mori

  2026-09-05

  A 2026 study in Bombyx mori identifies an ER-Ca2+-calpain signaling axis that links metabolic depletion to a time-dependent shift from protective autophagy to apoptosis in the insect fat body. Its use of 2-APB to suppress IP3R-associated calcium signaling provides pharmacological support for this mechanism while highlighting the value of temporal calcium measurements in nutritional-stress research.

• PD98059 Workflow for MAPK/ERK Studies

  2026-09-04

  PD98059 provides a reversible way to test whether MEK–ERK signaling drives lipid dysregulation, proliferation, or apoptosis. This workflow translates recent vascular toxicology findings into practical assay design, with concentration planning, temporal sampling, and troubleshooting guidance for reproducible mechanism studies.

• PS Nanoplastics–Cadmium Intestinal Apoptosis Pathway

  2026-09-04

  A 2026 Toxicology study combined a C. elegans model with Caco-2 cells to show that polystyrene nanoplastics and cadmium promote intestinal apoptosis through an IP3R/Ca2+/STAT3 signaling axis. Pharmacological inhibition, including intracellular calcium chelation with BAPTA, reduced apoptosis and supports a calcium-dependent mechanism relevant to environmental co-exposure research.

• Partial BACE Inhibition and Synaptic Transmission

  2026-09-03

  Satir et al. tested whether modest β-secretase inhibition can reduce amyloid-beta secretion without disrupting neuronal communication. Using primary rat cortical cultures, optical electrophysiology, and three BACE inhibitors including Lanabecestat (AZD3293), they found that amyloid-beta reduction below 50% preserved synaptic transmission, whereas stronger inhibition reduced both measures.

• How Cell Divisions Refine Drosophila Tissue Boundaries

  2026-09-03

  The reference study shows that cell division has a context-dependent role at the Drosophila mesectoderm–ectoderm boundary: it can promote mixing when actomyosin tension is lost, yet normally sharpen the interface by increasing ectodermal motility and reducing junctional tension. By combining mathematical modelling, quantitative microscopy, laser ablation, and cell tracking, the work identifies tissue fluidity as an active component of boundary refinement.

• Naftifine HCl: Assay Workflows and Optimization

  2026-09-02

  Naftifine HCl supports mechanism-oriented antifungal screening, from concentration-response assays to sterol-pathway confirmation. This guide emphasizes solvent control, orthogonal readouts, and careful separation between fungal pharmacology and the WNT5a/GSK3/β-catenin muscle biology highlighted in the reference study.

8457 records 2/564 page Previous Next 12345 下5页 Last page